Although the precise mechanisms by which hyperglycemia-induced inhibition of Akt and STAT3 activation compromise RPC-induced cardioprotection are not fully understood, the reduced expression of Cav-3 during hyperglycemia in diabetes might be a major factor [25, 26]. Here, STAT3 is linked to diabetes mellitus.